Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotein is considered a typical T-dependent antigen, but the nature of the T cell alloresponse that underpins alloantibody generation remains poorly understood. Here, we examine how the relative frequencies of alloantigen-specific B cells and helper CD4 T cells influence the humoral alloimmune response and how this relates to antibody-mediated rejection (AMR). An MHC-mismatched murine model of cardiac AMR was developed, in which T cell help for alloantibody responses in T cell deficient (Tcrbd−/−) C57BL/6 recipients against donor H-2Kd MHC class I alloantigen was provided by adoptively transferred “TCR75” CD4 T cells that recognize processed H-2Kd ...
This thesis examines the role played by CD4+ and CD8+ T cells in the rejection of a class I disparat...
Different profiles of alloantibody responses are observed in the clinic, with those that persist, of...
The T cell allorecognition pathways responsible for the rejection of MHC class I disparate allograft...
Humoral alloimmunity is now recognised as a major determinant of transplant outcome. 3 MHC glycoprot...
Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotei...
Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotei...
Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotei...
Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotei...
Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotei...
Different profiles of alloantibody responses are observed in the clinic, with those that persist, of...
Different profiles of alloantibody responses are observed in the clinic, with those that persist, of...
Summary: MHC alloantigen is recognized by two pathways: “directly,” intact on donor cells, or “indir...
SummaryMHC alloantigen is recognized by two pathways: “directly,” intact on donor cells, or “indirec...
MHC alloantigen is recognized by two pathways: "directly," intact on donor cells, or "indirectly," a...
The development of humoral autoimmunity following organ transplantation is increasingly recognised, ...
This thesis examines the role played by CD4+ and CD8+ T cells in the rejection of a class I disparat...
Different profiles of alloantibody responses are observed in the clinic, with those that persist, of...
The T cell allorecognition pathways responsible for the rejection of MHC class I disparate allograft...
Humoral alloimmunity is now recognised as a major determinant of transplant outcome. 3 MHC glycoprot...
Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotei...
Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotei...
Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotei...
Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotei...
Humoral alloimmunity is now recognized as a major determinant of transplant outcome. MHC glycoprotei...
Different profiles of alloantibody responses are observed in the clinic, with those that persist, of...
Different profiles of alloantibody responses are observed in the clinic, with those that persist, of...
Summary: MHC alloantigen is recognized by two pathways: “directly,” intact on donor cells, or “indir...
SummaryMHC alloantigen is recognized by two pathways: “directly,” intact on donor cells, or “indirec...
MHC alloantigen is recognized by two pathways: "directly," intact on donor cells, or "indirectly," a...
The development of humoral autoimmunity following organ transplantation is increasingly recognised, ...
This thesis examines the role played by CD4+ and CD8+ T cells in the rejection of a class I disparat...
Different profiles of alloantibody responses are observed in the clinic, with those that persist, of...
The T cell allorecognition pathways responsible for the rejection of MHC class I disparate allograft...